Skip to product information
1 of 1

Solgar Megasorb CoQ-10 200 mg 60 Softgels

Solgar Megasorb CoQ-10 200 mg 60 Softgels

Brand ownership disclosure
Nestlé Health Science
Nestlé S.A. (SIX: NESN)
Acquired 2021 via $5.75B Bountiful deal — Nestlé is keeping Solgar (premium tier)
Read reviews →
Also see: Amazon · Google · Reddit
Regular price $44.99 USD
Regular price Sale price $44.99 USD
Sale Sold out
Shipping calculated at checkout.
Quantity

The full picture

Everything Vyvata knows about this product — the score, the evidence, the FAQ, and where else to find shopper reviews. No hidden data. Every vendor is scored on the same published rubric — no brand can pay for placement. Read the rubric →

86/100
Verified

Six-dimension breakdown

Evidence
78
Formulation
78
Manufacturing
78
Safety
75
Transparency
72
Sustainability
55

Why this scored 86/100

[Rescored via evidence crawl] Previous score 76 → new 86. Evidence found: Bhagavan HN, Chopra RK. Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations. Mitochondrion. 2007;7 Suppl:S78-88. | Mortensen SA, et al. Q-SYMBIO trial: 300 mg/day CoQ10 reduced cardiovascular mortality in chronic heart failure. JACC Heart Fail. 2014;2(6):641-9. | Solgar Megasorb patent references for lipid-suspension softgel matrix.. Rationale: Megasorb lipid-carrier CoQ10 has TIER-B evidence for absorption advantage over dry powder (Bhagavan & Chopra 2007). 200 mg is within the clinically-studied range (100-300 mg) for statin repletion and general cardiac support. +10 uplift for proprietary formulation edge at an evidence-based dose.

Last scored: Full rubric →

Evidence & sources

The Vyvata score's Evidence dimension measures the quality of published RCT support for a product's active ingredients at the label dose. Our source hierarchy: double-blind RCTs in MEDLINE-indexed journals > single-blind RCTs > open-label trials > observational studies > mechanism papers > N=1 case studies (anecdotes). Predatory journals and manufacturer-authored studies without independent replication are weighted down.

Product-specific evidence citations for this item are embedded in the analysis text on the "Analysis" tab. For the full framework and evidence hierarchy, see the methodology page.

How to read the Evidence dimension

  • 80–100: Multiple double-blind RCTs in indexed journals directly testing this product OR the exact ingredients at the exact dose.
  • 60–79: Single double-blind RCT + supporting ingredient literature at the studied dose.
  • 40–59: Open-label trials + ingredient literature; no product-specific double-blind evidence.
  • 20–39: Ingredient literature only; no product-specific trials or trials in predatory venues.
  • 0–19: No credible evidence base or unverifiable claims.

Frequently asked questions

Auto-generated from Vyvata's scoring data for this product. For general questions about the store (shipping, returns, wholesale), see the site FAQ.

What is Solgar Megasorb CoQ-10 200 mg 60 Softgels?

Solgar Megasorb CoQ-10 200 mg 60 Softgels is a product from Solgar, categorized under Cardiovascular & heart health in the Supplements vertical. It is scored on the Vyvata Scoring Framework — an independent 6-dimension rubric applied uniformly to every product Vyvata lists.

How does Solgar Megasorb CoQ-10 200 mg 60 Softgels score on the Vyvata rubric?

76/100 overall — Verified tier (70–84 band). Per-dimension breakdown: Evidence 78, Formulation 78, Manufacturing 78, Safety 75, Transparency 72, Sustainability 55. Scored as of 2026-08-24.

Why did Solgar Megasorb CoQ-10 200 mg 60 Softgels score in the Verified tier?

Solgar Megasorb CoQ-10 200mg — practitioner-grade brand + softgel-with-oil delivery format ("Megasorb" is Solgar's oil-based softgel line for fat-soluble nutrients). 200mg is the sweet-spot dose for cardiovascular protocols + statin-associated myopathy adjunct (Skarlovnik 2014 RCT used ~200mg for statin myopathy relief). Ubiquinone form — fine for younger adults with intact conversion; over 40 or with reduced conversion capacity, ubiquinol form is preferred. Held below Elite by (1) no Kaneka Q10 sourcing confirmed at product name (Kaneka is the industry-standard Japanese raw material); (2) no third-party COA published per-SKU; (3) sustainability profile thin. Would move to Elite 85+ with Kaneka sourcing confirmation + published third-party assay.

What are the strongest and weakest aspects of this product?

Strongest: Evidence at 78/100 (quality of published RCT support for the active ingredients at the label dose) and Formulation at 78/100 (dose adequacy, bioavailability form, and ingredient redundancy). Weakest: Transparency at 72/100 (dose disclosure vs proprietary blends, and honesty of marketing claims) and Sustainability at 55/100 (sourcing practices, packaging, and corporate practice). All six dimensions feed the overall Vyvata score; a weakness on any one dimension pulls the overall down proportionally.

Is Solgar Megasorb CoQ-10 200 mg 60 Softgels third-party tested?

No third-party certifications (NSF, USP, ConsumerLab, or equivalent) were on record at the time of scoring. This affects the Manufacturing dimension score. The manufacturer may test internally or have obtained certification more recently — check the current product label for the most up-to-date information.

What would move Solgar Megasorb CoQ-10 200 mg 60 Softgels to a higher tier?

Would move to Elite 85+ with Kaneka sourcing confirmation + published third-party assay.

Are there higher-scoring alternatives to Solgar Megasorb CoQ-10 200 mg 60 Softgels?

The top-ranked cardiovascular & heart health product in the Vyvata catalog is currently Nordic Naturals Ultimate Omega 2X – High-Potency Fish Oil | 2150 mg EPA & DHA | Lemon Flavor, 120 Softgels at 87/100. See the full ranked list of 345 scored products in this subcategory at https://vyvata.com/pages/best-cardiovascular-and-heart-health-supplements-ranked.

What does the Vyvata score mean?

The Vyvata Scoring Framework rates every listed product 0–100 across six dimensions: Evidence, Formulation, Manufacturing, Safety, Transparency, and Sustainability. Tier bands: Elite 85–100 (top-tier evidence + formulation + manufacturing), Verified 70–84 (strong on most dimensions), Standard 50–69 (solid but with weaknesses called out), Rejected 0–49 (specific failures documented). Rejected products remain listed with reasons. Full methodology at https://vyvata.com/pages/methodology.

Where can I read customer reviews for Solgar Megasorb CoQ-10 200 mg 60 Softgels?

The Vyvata score measures product integrity against a published rubric, not customer sentiment. For customer reviews and community discussion, search external platforms directly: Amazon (https://www.amazon.com/s?k=Solgar%20Solgar%20Megasorb%20CoQ-10%20200%20mg%2060%20Softgels),Google(https://www.google.com/search?q=Solgar%20Solgar%20Megasorb%20CoQ-10%20200%20mg%2060%20Softgels+reviews),Reddit(https://www.reddit.com/search/?q=Solgar%20Solgar%20Megasorb%20CoQ-10%20200%20mg%2060%20Softgels%20review),andTrustpilot(https://www.trustpilot.com/search?query=Solgar%20Solgar%20Megasorb%20CoQ-10%20200%20mg%2060%20Softgels).Vyvatadoesnotaggregate,republish,orlicensethosethird-partyreviews.

Customer reviews

Reviews on other platforms

The Vyvata score measures product integrity against a published rubric, not customer sentiment. Vyvata does not aggregate, republish, or license third-party reviews — the links below open search pages on their respective platforms.

All the data we have on this product

Every VSF-related metafield surfaced verbatim. Nothing hidden. If you spot data that looks wrong, let us know.

VSF score
86 / 100
Tier
Verified
Category
Supplements
Subcategory
cardiovascular heart
Last scored
Third-party certifications
None on record at time of scoring
Vendor
Pasteur Pharmacy
Product type
Dietary Supplements
Tags
Pasteur Pharmacy, Shopify Collective

Every score is set from the published rubric, audit-logged, and rescored whenever new evidence emerges (published trials, updated labels, third-party testing releases). Every vendor is scored on the same criteria — no pay-to-play. See our editorial-independence disclosure for the full policy, including brands with an editorial relationship to this site.

View full details